Log in
NYSE:NTR

Nutrien Stock Forecast, Price & News

$40.73
-0.84 (-2.02 %)
(As of 10/26/2020 12:00 AM ET)
Add
Compare
Today's Range
$40.44
Now: $40.73
$41.33
50-Day Range
$36.91
MA: $40.00
$41.88
52-Week Range
$23.85
Now: $40.73
$50.78
Volume783,979 shs
Average Volume1.74 million shs
Market Capitalization$23.18 billion
P/E Ratio28.28
Dividend Yield4.33%
Beta0.81
Nutrien Ltd. produces and markets crop nutrients to agricultural, industrial, and feed customers worldwide. It operates in four segments: Retail, Potash, Nitrogen, and Phosphate and Sulfate. The company offers potash, nitrogen, phosphate, and sulfate products. It also distributes crop nutrients, crop protection products, seeds, and merchandise products through operating 1,700 retail locations. The company was incorporated in 2017 and is headquartered in Saskatoon, Canada.
Read More
Nutrien logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.4Community Rank: 2.7Dividend Strength: 1.7Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.12 out of 5 stars

Industry, Sector and Symbol

Industry Agricultural chemicals
Sub-IndustryN/A
CUSIPN/A
Phone306-933-8500
Employees22,300

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$20.02 billion
Cash Flow$5.44 per share
Book Value$39.92 per share

Profitability

Net Income$992 million

Miscellaneous

Market Cap$23.18 billion
Next Earnings Date11/2/2020 (Confirmed)
OptionableOptionable
$40.73
-0.84 (-2.02 %)
(As of 10/26/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive NTR News and Ratings via Email

Sign-up to receive the latest news and ratings for NTR and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Nutrien (NYSE:NTR) Frequently Asked Questions

How has Nutrien's stock price been impacted by Coronavirus?

Nutrien's stock was trading at $32.00 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, NTR shares have increased by 27.3% and is now trading at $40.73.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Nutrien?

21 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nutrien in the last year. There are currently 7 hold ratings, 13 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Nutrien
.

When is Nutrien's next earnings date?

Nutrien is scheduled to release its next quarterly earnings announcement on Monday, November 2nd 2020.
View our earnings forecast for Nutrien
.

How can I listen to Nutrien's earnings call?

Nutrien will be holding an earnings conference call on Monday, November 2nd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Nutrien's earnings last quarter?

Nutrien Ltd (NYSE:NTR) announced its quarterly earnings data on Monday, August, 10th. The company reported $1.45 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.37 by $0.08. The company had revenue of $8.42 billion for the quarter, compared to the consensus estimate of $8.32 billion. Nutrien had a net margin of 4.08% and a return on equity of 4.26%. Nutrien's revenue was down 3.2% compared to the same quarter last year. During the same period last year, the company earned $1.58 EPS.
View Nutrien's earnings history
.

How often does Nutrien pay dividends? What is the dividend yield for Nutrien?

Nutrien declared a quarterly dividend on Monday, August 10th. Investors of record on Wednesday, September 30th will be given a dividend of $0.45 per share on Friday, October 16th. This represents a $1.80 annualized dividend and a dividend yield of 4.42%. The ex-dividend date of this dividend is Tuesday, September 29th.
View Nutrien's dividend history
.

What guidance has Nutrien issued on next quarter's earnings?

Nutrien issued an update on its FY20 earnings guidance on Monday, August, 10th. The company provided EPS guidance of $1.50-1.90 for the period, compared to the Thomson Reuters consensus estimate of $1.62.

What price target have analysts set for NTR?

21 equities research analysts have issued 12 month price objectives for Nutrien's shares. Their forecasts range from $39.00 to $55.00. On average, they anticipate Nutrien's share price to reach $46.29 in the next twelve months. This suggests a possible upside of 13.7% from the stock's current price.
View analysts' price targets for Nutrien
.

Are investors shorting Nutrien?

Nutrien saw a increase in short interest in the month of September. As of September 30th, there was short interest totaling 5,510,000 shares, an increase of 42.4% from the September 15th total of 3,870,000 shares. Based on an average trading volume of 1,590,000 shares, the days-to-cover ratio is presently 3.5 days. Currently, 1.0% of the shares of the company are sold short.
View Nutrien's Short Interest
.

Who are some of Nutrien's key competitors?

What other stocks do shareholders of Nutrien own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nutrien investors own include AT&T (T), Pfizer (PFE), Johnson & Johnson (JNJ), General Electric (GE), Intel (INTC), Bank of America (BAC), CVS Health (CVS), AbbVie (ABBV), JPMorgan Chase & Co. (JPM) and Micron Technology (MU).

Who are Nutrien's key executives?

Nutrien's management team includes the following people:
  • Mr. Charles Victor Magro B.Sc. (Chem), MBA, Pres, CEO & Exec. Director (Age 49)
  • Mr. Frederick R. Thun, Sr. VP of Fin.
  • Mr. Michael J. Frank, Exec. VP & CEO of Retail (Age 55)
  • Mr. Pedro Farah, Exec. VP & CFO
  • Mr. Brent D. Poohkay, Exec. VP & Chief Information Officer (Age 49)

What is Nutrien's stock symbol?

Nutrien trades on the New York Stock Exchange (NYSE) under the ticker symbol "NTR."

Who are Nutrien's major shareholders?

Nutrien's stock is owned by many different institutional and retail investors. Top institutional investors include Galibier Capital Management Ltd. (0.21%), QV Investors Inc. (0.14%), PM CAPITAL Ltd (0.07%), Alberta Investment Management Corp (0.07%), Birch Hill Investment Advisors LLC (0.07%) and Standard Life Aberdeen plc (0.06%).

Which major investors are selling Nutrien stock?

NTR stock was sold by a variety of institutional investors in the last quarter, including Addenda Capital Inc., Hexavest Inc., Envestnet Asset Management Inc., Alberta Investment Management Corp, QV Investors Inc., Livingston Group Asset Management CO operating as Southport Capital Management, Lesa Sroufe & Co, and Bruderman Asset Management LLC.

Which major investors are buying Nutrien stock?

NTR stock was purchased by a variety of institutional investors in the last quarter, including Galibier Capital Management Ltd., PM CAPITAL Ltd, AMG National Trust Bank, Meritage Portfolio Management, Diversified Investment Strategies LLC, WealthTrust Axiom LLC, Pacifica Partners Inc., and Great Valley Advisor Group Inc..

How do I buy shares of Nutrien?

Shares of NTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Nutrien's stock price today?

One share of NTR stock can currently be purchased for approximately $40.73.

How big of a company is Nutrien?

Nutrien has a market capitalization of $23.18 billion and generates $20.02 billion in revenue each year. The company earns $992 million in net income (profit) each year or $2.17 on an earnings per share basis. Nutrien employs 22,300 workers across the globe.

What is Nutrien's official website?

The official website for Nutrien is www.nutrien.com.

How can I contact Nutrien?

Nutrien's mailing address is SUITE 500 122 - 1ST AVENUE SOUTH, SASKATOON A9, S7K 7G3. The company can be reached via phone at 306-933-8500 or via email at [email protected]

This page was last updated on 10/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.